726
Can. J. Chem. Vol. 80, 2002
H-4), 7.46 (m, 2H, H-meta), 7.58 (m, 1H, H-para), 8.05 (m,
2H, H-ortho).
plus 0.1 % (v/v) H3PO4 were employed at a flow rate of
1.0 mL min–1. Compounds trans-1a, trans-1b, cis-1a,
cis-1b, cis-2a, and cis-2b (retention times 5.6, 2.2, 5.0, 1.8,
5.5, and 2.1 min, respectively) were detected at 230 nm.
Compounds cis-3a, trans-4a, and cis-4a (retention times 5.4,
3.5, and 2.9 min, respectively) were detected by the refrac-
tive-index detector.
cis-2a
1H NMR d: 1.40–2.10 (m, 7H), 2.31 (m, 1H), 2.72 (tt, J =
3.5, 5.9, 9.2, 9.7 Hz, 1H, H-1), 5.04 (tt, J = 3.5, 5.0, 8.7,
8.8 Hz, 1H, H-3), 7.44 (m, 2H, H-meta), 7.53 (m, 1H,
H-para), 8.06 (m, 2H, H-ortho). 13C NMR d: 21.68 (C-5),
26.22 (C-6), 28.95 (C-4), 30.56 (C-2), 33.98 (C-1), 70.36
(C-3), 121.88 (CN), 128.62 (C-meta), 129.95 (C-ortho),
130.32 (C-ipso), 133.33 (C-para), 165.98 (C=O).
Isolation and identification of products
Amides trans-1b, cis-1b, and cis-2b were extracted from
supernatants of the reaction mixtures with ethyl acetate at
pH 8.5–8.8 (NaOH). The reaction mixtures from the
biotransformations of substrates trans-3a and trans-4a were
lyophilized and extracted with methanol to give the respec-
tive amides trans-3b and trans-4b.
trans-3a
1H NMR d: 1.10–1.44 (m, 4H, H-3, H-4, H-5, H-6), 1.51–
1.84 (m, 3H, H-4, H-5, H-6), 2.06 (m, 1H, H-3), 2.42 (ddd, J
= 11.5, 9.3, 3.8 Hz, 1H, H-1), 3.03 (br s, 1H, OH), 3.69 (dt,
J = 9.4, 4.2 Hz, 1H, H-2).
trans-1b
1H NMR d: 1.41–1.55 (m, 4H, H-2a, H-3a, H-5a, H-6a),
1.85 (m, 2H, H-2b, H-6b), 2.05 (m, 2H, H-3b, H-5b), 2.14
(m, S J = 29.7 Hz, 1H, H-1), 4.82 (m, S J = 29.7 Hz, 1H,
H-4), 6.71 (br s, 1H, NH), 7.25 (br s, 1H, NH), 7.52 (m, 2H,
H-meta), 7.64 (m, 1H, H-para), 7.94 (m, 2H, H-ortho). 13C
NMR d: 27.17 (t, C-2 and C-6), 30.60 (t, C-3 and C-5),
42.44 (d, C-1), 73.01 (d, C-4), 128.82 (d, C-meta), 129.19
(d, C-ortho), 130.25 (s, C-ipso), 133.33 (d, C-para), 165.29
(s, OCOPh), 176.80 (s, CONH2).
cis-3a
1H NMR d: 1.13–2.20 (m, 8H, H-3/3, H-4/4, H-5/5,
H-6/6), 3.01 (q, J = 3.1 Hz, 1H, H-1), 3.10 (br s, 1H, OH),
3.75 (dt, J = 8.4, 4.1, Hz, 1H, H-2).
trans-4a
1H NMR d: 1.48–2.30 (m, 6H), 2.65 (m, S J = 13.2 Hz,
1H, H-1), 3.68 (d, J = 3.5 Hz, 1H, OH), 4.37 (m, S J =
11.9 Hz, 1H, H-2).
cis-1b
cis-4a
1H NMR d: 1.60–1.80 (m, 6H, H-2, H-6, H-3a, H-5a),
1.93 (m, 2H, H-3b, H-5b), 2.22 (m, S J = 28.6 Hz, 1H, H-1),
5.14 (m, S J = 13.9 Hz, 1H, H-4), 6.71 (br s, 1H, NH), 7.23
(br s, 1H, NH), 7.55 (m, 2H, H-meta), 7.66 (m, 1H, H-para),
7.99 (m, 2H, H-ortho). 13C NMR d: 23.96 (t, C-2 and C-6),
28.77 (t, C-3 and C-5), 42.10 (d, C-1), 69.64 (d, C-4),
128.76 (d, C-meta), 129.06 (d, C-ortho), 130.38 (s, C-ipso),
133.20 (d, C-para), 165.01 (s, OCOPh), 176.78 (s, CONH2).
1H NMR d: 1.46–2.10 (m, 6H), 2.71 (dt, J = 8.3, 4.8 Hz,
1H, H-1), 3.65 (br s, 1H, OH), 4.35 (dt, J = 5.3, 3.5 Hz, 1H,
H-2).
General procedure of the biotransformation
The nitrile hydratase from Rhodococcus equi A4 (10) was
diluted with KH2PO4–Na2HPO4 buffer (54 mM, pH 7.5) to a
concentration of 22 g of protein mL–1 (42 g of pro-
tein mL–1 for cis-2a) and the substrates were added from
stock solutions in methanol to make up final concentrations
of 1.25 mM of trans-1a, cis-1a, and cis-2a and 5 mM of
trans-3a, cis-3a, trans-4a, and cis-4a. Methanol did not ex-
ceed 5% (v/v) of the reaction mixture. The reactions were
carried out in shaken vessels (850 rpm, Thermomixer Com-
pact Eppendorf) at 30°C. At intervals, samples were with-
drawn, the reaction was quenched with 1 M HCl (0.1 mL
per 1 mL of sample) and the precipitated protein was re-
moved by centrifugation. The supernatants were analyzed by
HPLC as described below or by TLC on silica gel plates
(Merck) developed with chloroform–ethyl acetate (10:1) (for
substrates trans-3a, cis-3a, trans-4a, and cis-4a); the spots
were visualized by charring with 5% sulphuric acid in etha-
nol.
cis-2b
1H NMR d: 1.27 (m, 1H, H-6a), 1.37 (m, 1H, H-4a), 1.38
(m, 1H, H-5a), 1.52 (d, J = 12.2 Hz, 1H, H-2a), 1.74 (m, 1H,
H-6b), 1.86 (m, 1H, H-5b), 2.01 (m, 1H, H-4b), 2.08 (m, S J =
23.6 Hz, 1H, H-2b), 2.30 (dd, J = 3.5, 11.9 Hz, 1H, H-1),
4.88 (dd, J = 4.4, 11.0 Hz, 1H, H-3), 6.73 (br s, 1H, NH),
7.25 (br s, 1H, NH), 7.52 (m, 2H, H-meta), 7.65 (m, 1H,
H-para), 7.95 (m, 2H, H-ortho). 13C NMR d: 23.07 (t, C-5),
28.19 (t, C-6), 31.01 (t, C-4), 34.33 (t, C-2), 41.97 (d, C-1),
72.92 (d, C-3), 128.71 (d, C-meta), 129.10 (d, C-ortho),
130.13 (s, C-ipso), 133.22 (d, C-para), 165.11 (s, OCOPh),
175.75 (s, CONH2).
trans-3b
1H NMR d: 1.01–1.24 (m, 3H, H-3a, H-4a, H-5a), 1.27
(m, 1H, H-6a), 1.54–1.72 (m, 3H, H-4b, H-5b, H-6b), 1.81
(m, 1H, H-3b), 1.94 (ddd, J = 3.7, 9.8, 12.2 Hz, 1H, H-1),
3.46 (m, 1H, H-2), 4.57 (d, J = 5.1 Hz, 1H, OH), 6.61 (br s,
1H, NH), 7.13 (br s, 1H, NH). 13C NMR d: 24.39 (t, C-4),
24.84 (t, C-5), 28.73 (t, C-6), 35.16 (t, C-3), 52.10 (d, C-1),
69.80 (d, C-2), 176.67 (s, CONH2).
Analytical HPLC
The concentrations of substrates and products were deter-
mined using an HPLC system consisting of a sol-
vent-delivery system 600 (Waters), a photo-diode array
detector 996 (Waters), and a refractive-index detector 2410
(Waters) and a Nova-Pak C18 column (5 m, 3.9 × 150 mm,
Waters). As mobile phases, 50% (v/v) acetonitrile (for com-
pounds trans-1a, trans-1b, cis-1a, cis-1b, cis-2a, and cis-2b)
or 10% (v/v) acetonitrile (for other compounds) in water
trans-4b
1H NMR d: 1.42 (m, 1H, H-3a), 1.50–1.64 (m, 3H, H-4a,
H-4b, H-5a), 1.68–1.83 (m, 2H, H-3b, H-5b), 2.39 (m, 1H,
© 2002 NRC Canada